Keele, UK-based Cobra Biologics is being handed £2.6 million by Innovate UK to help the firm expand and develop its infrastructure. More: Cobra awarded £2.6m from Innovate UK for expansion Source: News
read moreMylan has launched in the UK the first generic formulation of Teva’s multiple sclerosis blockbuster Copaxone, offering a potentially cheaper alternative for treatment of relapsing forms of the condition. More: Mylan launches Copaxone generic in the UK Source: News
read moreThe government has launched what it describes as a “landmark” independent review into prescription drug addiction in the UK. More: PHE to review prescription drug addition in the UK Source: News
read moreThe National Institute for Health and Care Excellence has given its backing for an online programme to be trialed on the NHS for the treatment of depression. More: NICE backs trial of online programme for depression Source: News
read moreEli Lilly has been given a green light to market Taltz in the European Union as a treatment for psoriatic arthritis. More: Lilly’s Taltz wins EU approval for psoriatic arthritis Source: News
read moreHere is some other vaccine news of note for the week. More: News of Note—Gritstone Oncology, Inovio Pharmaceuticals and more Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals